OBJECTIVE: Despite the clinical importance of early graft dysfunction, no standardized definition is available. We hypothesized that the arterial blood gas oxygen tension/fraction of inspired oxygen ratio (PaO2 /FIO2) would prove to be a useful marker for predicting subsequent outcomes of early graft dysfunction. The aims of this study were to define the prevalence of various ranges of PaO2 /FIO2 over the first 48 hours after lung transplantation and to evaluate which measurement using the PaO2 /FIO2 best correlates with the duration of intubation, the length of stay in the intensive care unit, and 30-day mortality, which are important alternative indicators of early graft performance. METHODS: A retrospective study was performed that included all 68 bilateral single-lung transplantations at The Alfred Hospital from January 2000 to December 2002. RESULTS: PaO2 /FIO2 at 6 and 12 hours after admission to the intensive care unit was significantly associated with the duration of intubation ( r = -0.44; P < .001 and r = -0.48; P < .001, respectively), and PaO2 /FIO2 at 6 and 24 hours was also significantly associated with the length of intensive care unit stay ( r = -0.38; P = .002 and r = -0.44; P = .001, respectively). Thirty-day mortality was significantly associated with a lower PaO2 /FIO2 at 6 hours (219 +/- 93 vs 306 +/- 101; P = .03). CONCLUSIONS: PaO2 /FIO2 taken between 6 and 12 hours after transplantation is a useful marker associated with lung transplantation outcomes. There is the potential for therapeutic interventions during this time that may be able to enhance PaO2 /FIO2 by 12 hours and improve subsequent outcomes.
OBJECTIVE: Despite the clinical importance of early graft dysfunction, no standardized definition is available. We hypothesized that the arterial blood gas oxygen tension/fraction of inspired oxygen ratio (PaO2 /FIO2) would prove to be a useful marker for predicting subsequent outcomes of early graft dysfunction. The aims of this study were to define the prevalence of various ranges of PaO2 /FIO2 over the first 48 hours after lung transplantation and to evaluate which measurement using the PaO2 /FIO2 best correlates with the duration of intubation, the length of stay in the intensive care unit, and 30-day mortality, which are important alternative indicators of early graft performance. METHODS: A retrospective study was performed that included all 68 bilateral single-lung transplantations at The Alfred Hospital from January 2000 to December 2002. RESULTS:PaO2 /FIO2 at 6 and 12 hours after admission to the intensive care unit was significantly associated with the duration of intubation ( r = -0.44; P < .001 and r = -0.48; P < .001, respectively), and PaO2 /FIO2 at 6 and 24 hours was also significantly associated with the length of intensive care unit stay ( r = -0.38; P = .002 and r = -0.44; P = .001, respectively). Thirty-day mortality was significantly associated with a lower PaO2 /FIO2 at 6 hours (219 +/- 93 vs 306 +/- 101; P = .03). CONCLUSIONS:PaO2 /FIO2 taken between 6 and 12 hours after transplantation is a useful marker associated with lung transplantation outcomes. There is the potential for therapeutic interventions during this time that may be able to enhance PaO2 /FIO2 by 12 hours and improve subsequent outcomes.
Authors: Gerhard Preissler; Florian Loehe; Ines V Huff; Ulrich Ebersberger; Vladimir V Shuvaev; Iris Bittmann; Iris Hermanns; James C Kirkpatrick; Karl Fischer; Martin E Eichhorn; Hauke Winter; Karl W Jauch; Steven M Albelda; Vladimir R Muzykantov; Rainer Wiewrodt Journal: Transplantation Date: 2011-08-27 Impact factor: 4.939